Profile	GDS3514 / 208561_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	194.055	40
GSM325241	Patient no. 1: treated	273.737	45
GSM325242	Patient no. 9: control	1158.24	78
GSM325243	Patient no. 9: treated	1224.7	79
GSM325244	Patient no. 18: control	356.54	47
GSM325245	Patient no. 18: treated	444.651	54
GSM325246	Patient no. 12: control	222.852	46
GSM325247	Patient no. 12: treated	187.635	43
GSM325248	Patient no. 3: control	131.902	36
GSM325249	Patient no. 3: treated	168.044	41
GSM325250	Patient no. 7: control	424.999	59
GSM325251	Patient no. 7: treated	389.712	58
GSM325252	Patient no. 15: control	358.212	51
GSM325253	Patient no. 15: treated	377.581	52
GSM325254	Patient no. 4: control	424.032	55
GSM325255	Patient no. 4: treated	869.443	70
GSM325256	Patient no. 19: control	1493.54	81
GSM325257	Patient no. 19: treated	2827.25	89
GSM325258	Patient no. 14: control	100.176	24
GSM325259	Patient no. 14: treated	181.893	31
GSM325260	Patient no. 13: control	173.587	32
GSM325261	Patient no. 13: treated	253.124	39
GSM325262	Patient no. 17: control	297.521	46
GSM325263	Patient no. 17: treated	102.9	22
GSM325264	Patient no. 10: control	258.985	45
GSM325265	Patient no. 10: treated	445.278	57
GSM325266	Patient no. 5: control	2338.47	86
GSM325267	Patient no. 5: treated	1229.45	78
GSM325268	Patient no. 11: control	219.989	37
GSM325269	Patient no. 11: treated	199.557	41
GSM325270	Patient no. 6: control	280.946	40
GSM325271	Patient no. 6: treated	120.379	31
GSM325272	Patient no. 8: control	817.553	69
GSM325273	Patient no. 8: treated	244.579	42
GSM325274	Patient no. 16: control	178.16	37
GSM325275	Patient no. 16: treated	237.742	44
GSM325276	Patient no. 2: control	240.031	40
GSM325277	Patient no. 2: treated	102.623	35